Serzone Pulled From U.S. Market by Bristol-Meyers Squibb
Wednesday, May 19th, 2004Source: Public Citizen Citing poor sells, Bristol-Myers Squibb said Wednesday that it will stop selling its controversial antidepressant drug Serzone in the United States as of June 14. But critics blame the drug’s risk of liver failure, which has brought many lawsuits against the company, for the withdrawal. Public Citizen, a consumer advocate group, said [...]